OTCM
PTAXY
Market cap2.57bUSD
, Last price
USD
Name
PALTAC Corp
Chart & performance
P/E
—
P/S
—
EPS
363.36
Div yield, %
—
Shrs. gr., 5y
-0.69%
Rev. gr., 5y
3.68%
Revenues
1.24t
+4.19%
Net income
22.03b
-3.64%
CFO
24.93b
+20.58%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Paltac Corporation engages in the wholesale of cosmetics, daily necessities, and over-the-counter drugs in Japan. Paltac Corporation was incorporated in 1928 and is headquartered in Osaka, Japan. Paltac Corporation operates as a subsidiary of MediPal Holdings Corporation.
Key people
Seiichi Kasutani
Chairman of the Board, Representative Director · since 2023
Masashi Maeda
Senior Managing Executive Officer, Chief Director of Information System · since 2021
Masakazu Mikita
Senior Managing Executive Officer, Chief Director of Research & Development · since 2023
Masahiro Noma
Senior Managing Executive Officer, Chief Senior Director of Administration, Director · since 2024
Tetsu Akiyama
Managing Executive Officer, President of Yokohama Office · since 2020
Koichi Inoue
Managing Executive Officer, Chief Director of Production · since 2025
Makoto Konishi
Managing Executive Officer, President of Kinki Office · since 2025
Akira Mikami
Managing Executive Officer, Chief Director of MCC Business · since 2025
Hiroshi Murai
Managing Executive Officer, Chief Director of SCM, President of Subsidiary · since 2023
Naoto Murao
Managing Executive Officer, Chief Director of Finance · since 2023
Mitsuhiko Seki
Managing Executive Officer, Chief Director of Store Support · since 2020
Takashi Uemura
Managing Executive Officer, President of Kyushu Office · since 2025
Yukiyo Yoshida
Managing Executive Officer, Chief Director of General Affairs · since 2021
Hideo Ashihara
Senior Managing Executive Officer, Chief Director of Sales · since 2025
Atsushi Hiyama
Executive Officer, Chief Director of Business Development · since 2025
Hideki Inaba
Executive Officer, Chief Director of LC Business · since 2024
Tadamichi Matsuie
Executive Officer, President of Tokyo Office · since 2025
Shohei Matsumoto
Executive Officer, Deputy Chief Director of Main Research and Development Unit · since 2023
Yuji Mikami
Executive Officer, President of Tohoku Office · since 2023
Hiroaki Muraki
Executive Officer, Chief Director of CSR Promotion · since 2023
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||